Microbiological Pathology

Medicine & Life Sciences

1. South Africa 100%
2. AIDS Vaccines 41%
3. HIV 39%
4. Vaccines 32%
5. HIV-1 21%
6. HIV Infections 16%
7. Acinetobacter baumannii 15%
8. Vaccination 13%
9. Immunization 11%
10. Placebos 11%
11. Candidemia 11%
12. Whole Genome Sequencing 10%
13. Multidrug-Resistant Tuberculosis 10%
14. Risk-Taking 9%
15. Safety 9%
16. Genes 8%
17. Hepatitis B virus 8%
18. ceftaroline fosamil 7%
19. Namibia 7%
20. Colistin 7%
21. Central Nervous System Fungal Infections 7%
22. Polymerase Chain Reaction 7%
23. Tertiary Care Centers 7%
24. Infections 7%
25. Autopsy 7%
26. Pregnancy 6%
27. Pregnant Women 6%
28. Serogroup 6%
29. Incidence 6%
30. Mycoplasma genitalium 6%
31. Papillomavirus Vaccines 6%
32. Fluconazole 6%
33. Laboratory Infection 6%
34. Foams and Jellies Vaginal Creams 6%
35. Viral Load 6%
36. Genotype 6%
37. Mycoplasma Infections 5%
38. Fungemia 5%
39. Sentinel Surveillance 5%
40. Tenofovir 5%
41. Disease Outbreaks 5%
42. Uganda 5%
43. vpu Genes 5%
44. Sexual Health 5%
45. Kenya 5%
46. Ceftriaxone 5%
47. T-Lymphocytes 5%
48. Edible Plants 5%
49. Immunization Programs 5%
50. Urethritis 5%
51. Candida parapsilosis 5%
52. Coinfection 5%
53. Clinical Trials 5%
54. Population 5%
55. Candida 5%
56. Sexually Transmitted Diseases 5%
57. Multiple Drug Resistance 5%
58. Eswatini 5%
59. Bacterial Meningitides 5%
60. Streptococcus 5%
61. Streptococcus agalactiae 5%
62. Salmonella enterica 5%
63. Trans-Activators 5%
64. Phase II Clinical Trials 5%
65. Real-Time Polymerase Chain Reaction 5%
66. Genetic Variation 5%